Gender identity: Current concepts and gender-affirming hormone therapy.
Cisgender
Cisgénero
Gender-affirming hormone therapy
Género no binario
Medicina transgénero
Nonbinary gender
Transgender
Transgender medicine
Transgénero
Transición
Transition
Tratamiento hormonal de afirmación de género
Journal
Endocrinologia, diabetes y nutricion
ISSN: 2530-0180
Titre abrégé: Endocrinol Diabetes Nutr (Engl Ed)
Pays: Spain
ID NLM: 101717565
Informations de publication
Date de publication:
Mar 2023
Mar 2023
Historique:
received:
02
01
2022
accepted:
06
02
2022
pubmed:
22
12
2022
medline:
22
3
2023
entrez:
21
12
2022
Statut:
ppublish
Résumé
In the past five years, healthcare organisation for trans people in Spain has changed as laws intended to protect sexual and gender diversity have been put in place. As a result, endocrinologists are not only on the front lines (understood as prescribing and following up gender-affirming hormone therapy) but also coordinating multidisciplinary healthcare for these individuals. Advances in transgender medicine, the complexity of diverse trans identities and the impact of hormone therapy on quality of life and risk of middle- and long-term complications call for in-depth examination of a personalised biopsychosocial approach to trans people that requires specific training in this field of knowledge as well as updates on the concepts, terminology and drug treatments used.
Identifiants
pubmed: 36543601
pii: S2530-0180(22)00165-2
doi: 10.1016/j.endien.2022.11.007
pii:
doi:
Substances chimiques
Hormones
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
27-37Informations de copyright
Copyright © 2022 SEEN and SED. Published by Elsevier España, S.L.U. All rights reserved.